Cyfra 21-1 marker in carcinoma of the cervix

International Journal of Gynecological Cancer

Volumn 10, Issue 3, 2000, Pages 203-206

  Yazigi, R ^a   Castillo, R ^b   Aliste, G ^b   Garrido, J ^b   Opazo, A ^b   Prado, S ^b   Navarro, C ^b   Altieri, E ^a   Del Campo, G ^b  

^a CLÍNICA LAS CONDES   (Chile)

^b Institute Nacional del Cáncer   (Chile)

Author keywords

Cancer; Cervix neoplasm; Cervix uteri; Cyfra 21 1; Tumor marker

Indexed keywords

CYTOKERATIN 19 FRAGMENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0033874327     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010003203.x     Document Type: Article

References (11)

1. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
2. Immuno-histochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies
3. Cyfra 21-1: A new marker in lung cancer
4. Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer
5. Tumor markers in gynecologic oncology
6. Cytokeratin fragment 21-1 in gynecologic malignancy: Comparison with cancer antigen 125 and squamous cell carcinoma-related antigen
7. Cytokeratin subunit 19 measures by CYFRA 21-1 assay in follow-up of cervical cancer
8. Study of a new tumor marker, CYFRA 21-1 in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen
9. Determination of serum levels of different cytokeratins in patients with uterine malignancies
10. Cyfra 21-1 in monitoring cervical cancer: A comparison with tissue polypeptide antigen and squamous cell carcinoma antigen
11. Cancer of the uterine cervix: Sensitivity and specificity of serum Cyfra 21.1 determinations